Validation of a needs-based biopsychosocial distress instrument for cancer patients

Psycho-Oncology

Volumn 21, Issue 10, 2012, Pages 1099-1106

  Lowery, Amy E ^a   Greenberg, Melanie A ^b   Foster, Sharon L ^c   Clark, Karen ^d   Casden, Danielle R ^e   Loscalzo, Matthew ^d   Bardwell, Wayne A ^e  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c ALLIANT INTERNATIONAL UNIVERSITY   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

anxiety; cancer; depression; distress; needs assessment; oncology

Indexed keywords

ADULT; ANXIETY; ARTICLE; BREAST CANCER; BRIEF SYMPTOM INVENTORY; CANCER NEEDS DISTRESS INVENTORY; CANCER PATIENT; CANCER STAGING; CANCER THERAPY; CHRONIC LYMPHATIC LEUKEMIA; COLON CANCER; CONSTRUCT VALIDITY; DEPRESSION; DISCRIMINANT VALIDITY; DISTRESS SYNDROME; EDUCATIONAL STATUS; EMOTION; FEMALE; FUNCTIONAL ASSESSMENT; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INCOME; INSTRUMENT VALIDATION; INTERNAL CONSISTENCY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MYELOMA; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEEDS ASSESSMENT; NEOPLASM; OVARY CANCER; PREDICTIVE VALUE; PSYCHOLOGIC TEST; PSYCHOMETRY; RECEIVER OPERATING CHARACTERISTIC; RECTUM CANCER; SENSITIVITY AND SPECIFICITY; SOCIAL DESIRABILITY; SOCIAL STATUS; TEST RETEST RELIABILITY;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEEDS ASSESSMENT; NEOPLASMS; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF REPORT; SENSITIVITY AND SPECIFICITY; SOCIAL DESIRABILITY; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL;

EID: 84867209030     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.2008     Document Type: Article

References (50)

1. Thune-Boyle IC, Myers LB, Newman SP,. The role of illness beliefs, treatment beliefs, and perceived severity of symptoms in explaining distress in cancer patients during chemotherapy treatment. Behav Med 2006; 32 (1): 19-29.
2. Hwang SS, Chang VT, Rue M, et al,. Multidimensional independent predictors of cancer-related fatigue. J Pain Symptom Manage 2003; 26 (1): 604-14.
3. Kunkel EJ, Bakker JR, Myers RE, et al,. Biopsychosocial aspects of prostate cancer. Psychosomatics 2000; 41 (2): 85-94.
4. Syrjala KL, Chapko ME,. Evidence for a biopsychosocial model of cancer treatment-related pain. Pain 1995; 61 (1): 69-79.
5. National Comprehensive Cancer Network: Distress Management Clinical Practice Guidelines. J Natl Compr Canc Netw 2003; 1: 344-374.
6. Skarstein J, Aass N, Fossa SD, et al,. Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire. J Psychosom Res 2000; 49 (1): 27-34.
7. Kennard BD, Stewart SM, Olvera R, et al,. Nonadherence in adolescent oncology patients: preliminary data on psychological risk factors and relationships to outcome. J Clin Psychol Med Settings 2004; 11 (1): 31-39.
8. Degner LF, Sloan JA,. Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manage 1995; 10 (6): 423-31.
9. Gilbar O,. The connection between the psychological condition of breast cancer patients and survival. A follow-up after eight years. Gen Hosp Psychiatry 1996; 18 (4): 266-70.
10. Palmer JL, Fisch MJ,. Association between symptom distress and survival in outpatients seen in a palliative care cancer center. J Pain Symptom Manage 2005; 29 (6): 565-71.
11. Cancer Facts and Figures 2007. American Cancer Society, 2007.
12. Ashbury FD, Findlay H, Reynolds B, et al,. A Canadian survey of cancer patients' experiences: are their needs being met? J Pain Symptom Manage 1998; 16 (5): 298-306.
13. Fortner BV, Demarco G, Irving G, et al,. Description and predictors of direct and indirect costs of pain reported by cancer patients. J Pain Symptom Manage 2003; 25 (1): 9-18.
14. Bottomley A,. Depression in cancer patients: a literature review. Eur J Cancer Care (Engl) 1998; 7 (3): 181-91.
15. van't Spijker A, Trijsburg RW, Duivenvoorden HJ,. Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 1997; 59 (3): 280-93.
16. Vos PJ, Visser AP, Garssen B, et al,. Effects of delayed psychosocial interventions versus early psychosocial interventions for women with early stage breast cancer. Patient Educ Couns 2006; 60 (2): 212-9.
17. Berard RM, Boermeester F, Viljoen G,. Depressive disorders in an out-patient oncology setting: prevalence, assessment, and management. Psychooncology 1998; 7 (2): 112-20.
18. Sollner W, DeVries A, Steixner E, et al,. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer 2001; 84 (2): 179-85.
19. Fallowfield L, Ratcliffe D, Jenkins V, et al,. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001; 84 (8): 1011-5.
20. Zabora JR,. Screening procedures for psychosocial. In Psycho-Oncology, Holland JC, (ed.), Oxford University Press: New York NY, 1998; 653-661.
21. Carlson LE, Bultz BD,. Cancer distress screening. Needs, models, and methods. J Psychosom Res 2003; 55 (5): 403-9.
22. Wright EP, Selby PJ, Gould A, et al,. Detecting social problems in cancer patients. Psycho-Oncology 2001; 10 (3): 242-50.
23. Payne DK, Hoffnan RG, Theodoulou M, et al,. Screening for anxiety and depression in women with breast cancer. Psychiatry and medical oncology gear up for managed care. Psychosomatics 1999; 40 (1): 64-9.
24. Institute of Medicine. Cancer Care for the Whole Patient. National Academics Press: Washington DC, 2007.
25. Clark K, Bardwell WA, Arsenault T, et al,. Implementing touch-screen technology to enhance recognition of distress. Psychooncology 2009; 18 (8): 822-30.
26. Zabora JR, Loscalzo MJ, Weber J,. Managing complications in cancer: identifying and responding to the patient's perspective. Semin Oncol Nurs 2003; 19 (4 Suppl 2): 1-9.
27. Faul F, Erdfelder E, Buchner A, et al,. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009; 41: 1149-1160.
28. US Food and Drug Administration: Guidance for Industry: Patient Reported Outcome Measures-Use in Medical Product Development to Support Labeling Claims. Department of Health and Human Services: Rockville, MD, 2009.
29. Engel GL,. The need for a new medical model: a challenge for biomedicine. Science 1977; 196 (4286): 129-36.
30. Zigmond AS, Snaith RP,. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67 (6): 361-70.
31. Herschbach P, Berg P, Dankert A, et al,. Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire. J Psychosom Res 2005; 58 (6): 505-11.
32. Jacobsen PB, Donovan KA, Trask PC, et al,. Screening for psychologic distress in ambulatory cancer patients. Cancer 2005; 103 (7): 1494-502.
33. Wright EP, Kiely M, Johnston C, et al,. Development and evaluation of an instrument to assess social difficulties in routine oncology practice. Qual Life Res 2005; 14 (2): 373-86.
34. Derogatis LR, Melisaratos N,. The Brief Symptom Inventory: an introductory report. Psychol Med 1983; 13 (3): 595-605.
35. Hoffman BM, Zevon MA, D'Arrigo MC, et al,. Screening for distress in cancer patients: the NCCN rapid-screening measure. Psycho-Oncology 2004; 13 (11): 792-9.
36. Webster K, Odom L, Peterman A, et al,. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: validation of version four of the core questionnaire. Qual Life Res 1999; 8: 604.
37. Chang VT, Hwang SS, Feuerman M, et al,. The Memorial Symptom Assessment Scale short form (MSAS-SF). Cancer 2000; 89 (5): 1162-71.
38. Chang VT, Hwang SS, Kasimis B, et al,. Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS). Cancer Invest 2004; 22 (4): 526-36.
39. Loblaw DA, Bezjak A, Singh PM, et al,. Psychometric refinement of an outpatient, visit-specific satisfaction with doctor questionnaire. Psycho-Oncology 2004; 13 (4): 223-34.
40. Peterman AH, Fitchett G, Brady MJ, et al,. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy-Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med 2002; 24 (1): 49-58.
41. Ward WL, Hahn EA, Mo F, et al,. Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res 1999; 8 (3): 181-95.
42. Cella DF, Tulsky DS, Gray G, et al,. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11 (3): 570-9.
43. Paulhus DL,. Paulhus Deception Scale (PDS): The Balanced Inventory of Desirable Responding-7. Multi-Health Systems Inc.: North Tonawanda NY, 1998.
44. Cormier JN, Ross MI, Gershenwald JE, et al,. Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire. Cancer 2008; 112 (10): 2249-57.
45. Rainbird KJ, Perkins JJ, Sanson-Fisher RW,. The Needs Assessment for Advanced Cancer Patients (NA-ACP): a measure of the perceived needs of patients with advanced, incurable cancer. a study of validity, reliability and acceptability. Psycho-Oncology 2005; 14 (4): 297-306.
46. Schag CA, Ganz PA, Heinrich RL,. CAncer Rehabilitation Evaluation System-short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument. Cancer 1991; 68 (6): 1406-13.
47. Schag CA, Heinrich RL, Aadland RL, et al,. Assessing problems of cancer patients: psychometric properties of the cancer inventory of problem situations. Health Psychol 1990; 9 (1): 83-102.
48. Bruning JL, Kintz BL,. Computational Handbook of Statistics. Scott, Foresman and Company: Glenview, IL, 1987.
49. Johnson ME, Chipp CL, Brems C, et al,. Receiver operating characteristics for the brief symptom inventory depression, paranoid ideation, and psychoticism scales in a large sample of clinical inpatients. Psychol Rep 2008; 102 (3): 695-705.
50. In SEER Cancer Statistics Review, 1975-2005, Ries LAG, et al (eds.). Bethesda MD, 2008. http://seer.cancer.gov/csr/1975-2005/, based on November 2007 SEER data submission, posted to the SEER web site, 2008.